Bicycle Therapeutics (BCYC) Operating Margin Growth (5y) (2023 - 2026)
Bicycle Therapeutics (BCYC) Operating Margin Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Bicycle Therapeutics | 279.33 Mn | 279.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -649,613.00 |
| Dec 31, 2025 | 39,182.00 |
| Sep 30, 2025 | -28,079.00 |
| Jun 30, 2025 | -216,487.00 |
| Mar 31, 2025 | 32,761.00 |
| Dec 31, 2024 | -173,457.00 |
| Sep 30, 2024 | -71,600.00 |
| Jun 30, 2024 | 2,652.00 |
| Mar 31, 2024 | -25,336.00 |
| Dec 31, 2023 | -30,382.00 |
| Sep 30, 2023 | -55,428.00 |
| Jun 30, 2023 | -7,977.00 |